The KPNA6 Knockout HeLa Polyclonal Cells product provides a CRISPR/Cas9-mediated gene-disrupted polyclonal cell population derived from HeLa cells. This knockout model targets the KPNA6 gene, encoding importin alpha 7, a critical adaptor for classical nuclear import. The polyclonal composition ensures representation of multiple editing events, offering a robust loss-of-function model for studying KPNA6-dependent nuclear transport without clonal isolation bias.
HeLa cells are an immortalized human cervical adenocarcinoma cell line with integrated HPV18 DNA, widely used in cancer research, virology, and signal transduction studies. Their epithelial origin and stable karyotype make them a suitable host for probing nucleocytoplasmic shuttling mechanisms altered by viral oncoproteins.
KPNA6 functions as an importin alpha adaptor that recognizes classical nuclear localization signals (NLS) on cargo proteins. In complex with KPNB1 (importin beta 1), it facilitates RanGTPase-dependent translocation through the nuclear pore complex. KPNA6 is activated by upstream interferon-gamma signaling and mediates nuclear import of transcription factors including STAT1, STAT2, p53, and NF-??B (p65). These factors regulate gene expression programs involved in antiviral responses, apoptosis, and cell cycle control. Additionally, KPNA6 may interact with HPV oncoproteins E6 and E7, influencing viral pathogenesis.
In HeLa cells, KPNA6-mediated nuclear import is crucial for the function of tumor suppressors and immune regulators. Disruption of KPNA6 impairs the nuclear accumulation of STAT1/STAT2, dampening interferon-stimulated gene expression and compromising antiviral and antitumor responses. It also attenuates p53-mediated transcription and NF-??B signaling, potentially disrupting HPV E6/E7 activities that rely on these pathways. Thus, this knockout model reveals how nuclear import modulation impacts cervical cancer cell biology and HPV-host interactions.
This product supports a wide range of applications, including investigation of nucleocytoplasmic transport dynamics, interferon signaling cascades, and HPV oncoprotein function. Researchers can employ nuclear/cytoplasmic fractionation followed by Western blotting to assess cargo redistribution, immunofluorescence to visualize protein localization, and RT-qPCR or RNA-seq for global transcriptomic changes. Co-immunoprecipitation with KPNB1 or NUP62 enables study of import complex assembly. Functional assays such as STAT1-dependent luciferase reporters, flow cytometric cell cycle analysis, and drug sensitivity testing with importin inhibitors further dissect KPNA6-dependent phenotypes. For additional technical details, please contact Ascent Research.
